Pyk2 and Src mediate signaling to CCL18-induced breast cancer metastasis

Journal of Cellular Biochemistry

Volumn 115, Issue 3, 2014, Pages 596-603

  Li, Hai Yan ^a,b   Cui, Xiu Ying ^a   Wu, Wei ^a   Yu, Feng Yan ^a   Yao, He Rui ^a   Liu, Qiang ^a   Song, Er Wei ^a   Chen, Jing Qi ^a,c  

^a SUN YAT SEN UNIVERSITY   (China)

^b THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^c GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

CCL18; INTEGRIN; METASTASIS; Pyk2; Src

Indexed keywords

ALPHA5 INTEGRIN; BETA1 INTEGRIN; CCL18 CHEMOKINE; CHEMOKINE; FOCAL ADHESION KINASE 2; PHOSPHOTRANSFERASE; SRC KINASE; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; BREAST METASTASIS; CANCER CELL; CELL INVASION; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; CYTOPLASM; ENZYME ACTIVATION; GENE TRANSLOCATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; ONCOGENE SRC; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STIMULATION; WESTERN BLOTTING;

CCL18; INTEGRIN; METASTASIS; PYK2; SRC;

BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CHEMOKINES, CC; FEMALE; FOCAL ADHESION KINASE 2; HUMANS; MEMBRANE PROTEINS; NEOPLASM METASTASIS; SRC-FAMILY KINASES;

EID: 84892741400     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24697     Document Type: Article

References (32)

1. Andreev J, Simon JP, Sabatini DD, Kam J, Plowman G, Randazzo PA, Schlessinger J,. 1999. Identification of a new Pyk2 target protein with Arf-GAP activity. Mol Cell Biol 19: 2338-2350.
2. Bartos JA, Ulrich JD, Li H, Beazely MA, Chen Y, Macdonald JF, Hell JW,. 2010. Postsynaptic clustering and activation of Pyk2 by PSD-95. J Neurosci 30: 449-463.
3. Bianchi-Smiraglia A, Paesante S, Bakin AV,. 2012. Integrin beta5 contributes to the tumorigenic potential of breast cancer cells through the Src-FAK and MEK-ERK signaling pathways. Oncogene 32 (25): 3049-3058.
4. Cao J, Chen Y, Fu J, Qian YW, Ren YB, Su B, Luo T, Dai RY, Huang L, Yan JJ, Wu MC, Yan YQ, Wang HY,. 2012. High expression of proline-rich tyrosine kinase2 is associated with poor survival of hepatocellular carcinoma via regulating phosphatidylinositol 3-kinase/AKT pathway. Ann Surg Oncol DOI: 10.1245/s10434-012-2372-9
5. Chen J, Yao Y, Gong C, Yu F, Su S, Liu B, Deng H, Wang F, Lin L, Yao H, Su F, Anderson KS, Liu Q, Ewen ME, Yao X, Song E,. 2011. CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3. Cancer Cell 19: 541-555.
6. Cheng GZ, Chan J, Wang Q, Zhang W, Sun CD, Wang LH,. 2007. Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel. Cancer Res 67: 1979-1987.
7. Cheung R, Ravyn V, Wang L, Ptasznik A, Collman RG,. 2008. Signaling mechanism of HIV-1 gp120 and virion-induced IL-1beta release in primary human macrophages. J Immunol 180: 6675-6684.
8. Cheung R, Malik M, Ravyn V, Tomkowicz B, Ptasznik A, Collman RG,. 2009. An arrestin-dependent multi-kinase signaling complex mediates MIP-1beta/CCL4 signaling and chemotaxis of primary human macrophages. J Leukoc Biol 86: 833-845.
9. Dikic I, Schlessinger J,. 1998. Identification of a new Pyk2 isoform implicated in chemokine and antigen receptor signaling. J Biol Chem 273: 14301-14308.
10. Dikic I, Tokiwa G, Lev S, Courtneidge SA, Schlessinger J,. 1996. A role for Pyk2 and Src in linking G-protein-coupled receptors with MAP kinase activation. Nature 383: 547-550.
11. Du QS, Ren XR, Xie Y, Wang Q, Mei L, Xiong WC,. 2001. Inhibition of PYK2-induced actin cytoskeleton reorganization, PYK2 autophosphorylation and focal adhesion targeting by FAK. J Cell Sci 114: 2977-2987.
12. Duong LT, Lakkakorpi PT, Nakamura I, Machwate M, Nagy RM, Rodan GA,. 1998. PYK2 in osteoclasts is an adhesion kinase, localized in the sealing zone, activated by ligation of alpha(v)beta3 integrin, and phosphorylated by src kinase. J Clin Invest 102: 881-892.
13. Duong LT, Nakamura I, Lakkakorpi PT, Lipfert L, Bett AJ, Rodan GA,. 2001. Inhibition of osteoclast function by adenovirus expressing antisense protein-tyrosine kinase 2. J Biol Chem 276: 7484-7492.
14. Frame MC,. 2002. Src in cancer: Deregulation and consequences for cell behaviour. Biochim Biophys Acta 1602: 114-130.
15. Genua M, Xu SQ, Buraschi S, Peiper SC, Gomella LG, Belfiore A, Iozzo RV, Morrione A,. Proline-rich tyrosine kinase 2 (Pyk2) regulates IGF-I-induced cell motility and invasion of urothelial carcinoma cells. PLoS ONE 7: e40148.
16. Gutenberg A, Bruck W, Buchfelder M, Ludwig HC,. 2004. Expression of tyrosine kinases FAK and Pyk2 in 331 human astrocytomas. Acta Neuropathol 108: 224-230.
17. Hinton CV, Avraham S, Avraham HK,. 2008. Contributions of integrin-linked kinase to breast cancer metastasis and tumourigenesis. J Cell Mol Med 12: 1517-1526.
18. Huang Y, Lu W, Ali DW, Pelkey KA, Pitcher GM, Lu YM, Aoto H, Roder JC, Sasaki T, Salter MW, MacDonald JF,. 2001. CAKbeta/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus. Neuron 29: 485-496.
19. Iiizumi M, Bandyopadhyay S, Pai SK, Watabe M, Hirota S, Hosobe S, Tsukada T, Miura K, Saito K, Furuta E, Liu W, Xing F, Okuda H, Kobayashi A, Watabe K,. 2008. RhoC promotes metastasis via activation of the Pyk2 pathway in prostate cancer. Cancer Res 68: 7613-7620.
20. Lakkakorpi PT, Bett AJ, Lipfert L, Rodan GA, Duong le T,. 2003. PYK2 autophosphorylation, but not kinase activity, is necessary for adhesion-induced association with c-Src, osteoclast spreading, and bone resorption. J Biol Chem 278: 11502-11512.
21. Lev S,. 2001. Molecular aspects of retinal degenerative diseases. Cell Mol Neurobiol 21: 575-589.
22. Lev S, Hernandez J, Martinez R, Chen A, Plowman G, Schlessinger J,. 1999. Identification of a novel family of targets of PYK2 related to Drosophila retinal degeneration B (rdgB) protein. Mol Cell Biol 19: 2278-2288.
23. Litvak V, Tian D, Shaul YD, Lev S,. 2000. Targeting of PYK2 to focal adhesions as a cellular mechanism for convergence between integrins and G protein-coupled receptor signaling cascades. J Biol Chem 275: 32736-32746.
24. McShan GD, Zagozdzon R, Park SY, Zrihan-Licht S, Fu Y, Avraham S, Avraham H,. 2002. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration. Int J Oncol 21: 197-205.
25. Park SY, Avraham HK, Avraham S,. 2004. RAFTK/Pyk2 activation is mediated by trans-acting autophosphorylation in a Src-independent manner. J Biol Chem 279: 33315-33322.
26. Sieg DJ, Ilic D, Jones KC, Damsky CH, Hunter T, Schlaepfer DD,. 1998. Pyk2 and Src-family protein-tyrosine kinases compensate for the loss of FAK in fibronectin-stimulated signaling events but Pyk2 does not fully function to enhance FAK- cell migration. EMBO J 17: 5933-5947.
27. Sun CK, Ng KT, Sun BS, Ho JW, Lee TK, Ng I, Poon RT, Lo CM, Liu CL, Man K, Fan ST,. 2007. The significance of proline-rich tyrosine kinase2 (Pyk2) on hepatocellular carcinoma progression and recurrence. Br J Cancer 97: 50-57.
28. Sun CK, Man K, Ng KT, Ho JW, Lim ZX, Cheng Q, Lo CM, Poon RT, Fan ST,. 2008. Proline-rich tyrosine kinase 2 (Pyk2) promotes proliferation and invasiveness of hepatocellular carcinoma cells through c-Src/ERK activation. Carcinogenesis 29: 2096-2105.
29. Tse KW, Lin KB, Dang-Lawson M, Guzman-Perez A, Aspnes GE, Buckbinder L, Gold MR, Small molecule inhibitors of the Pyk2 and FAK kinases modulate chemoattractant-induced migration, adhesion and Akt activation in follicular and marginal zone B cells. Cell Immunol 275: 47-54.
30. Wendt MK, Schiemann BJ, Parvani JG, Lee YH, Kang Y, Schiemann WP,. 2012. TGF-beta stimulates Pyk2 expression as part of an epithelial-mesenchymal transition program required for metastatic outgrowth of breast cancer. Oncogene 32 (16): 2005-2015.
31. Yang L, Liu F, Xu Z, Guo N, Zheng X, Sun C,. Chemokine receptor 7 via proline-rich tyrosine kinase-2 upregulates the chemotaxis and migration ability of squamous cell carcinoma of the head and neck. Oncol Rep 28 (5): 1659-1664.
32. Zrihan-Licht S, Fu Y, Settleman J, Schinkmann K, Shaw L, Keydar I, Avraham S, Avraham H,. 2000. RAFTK/Pyk2 tyrosine kinase mediates the association of p190 RhoGAP with RasGAP and is involved in breast cancer cell invasion. Oncogene 19: 1318-1328.